Biologic Videos
-
Sustainable Manufacturing Through Automation, Flow Chemistry, And Biocataysis
3/12/2026
Learn how modeling, high-throughput tools, and advanced analytics enable safer, more efficient routes and support scalable solutions for complex chemical and enzymatic processes.
-
My Journey at Asymchem
3/12/2026
From flow chemistry to biocatalysis and synthetic biology, he shares how these platform technologies are transforming customer projects — and extending impact to the food, agriculture, and energy industries.
-
Quick View Of Asymchem's New OEB5 Facility
3/12/2026
Explore Asymchem’s OEB5 high-potency facility — a 6,000 m², fully enclosed site integrating R&D, manufacturing, and analytics under CPT ≤1 ng/m³ containment.
-
Asymchem's State-Of-The-Art HTE Platform
3/12/2026
Steve Fussell, Senior Manager – High-Throughput Experimentation (HTE) at Asymchem, introduces our state-of-the-art HTE laboratory, where automation, robotics, and data-driven insights transform process R&D.
-
ROIS Capabilities Update March 2026: Fill/Finish
3/10/2026
End‑to‑end aseptic fill‑finish services across multiple injectable formats, supporting biologics and small molecules with advanced capabilities and available large‑scale capacity.
-
medac CDMO Capabilities Update March 2026: Fill/Finish
3/10/2026
A purpose‑built sterile manufacturing model enables reliable scale‑up, operational agility, and resilient global supply for complex injectables, supported by strong infrastructure and process design.
-
Jubilant HollisterStier Capabilities Update March 2026: Fill/Finish
3/10/2026
Reliable sterile manufacturing requires tailored support and consistent execution. Collaboration and strong quality systems help teams advance complex injectable products with confidence.
-
Argonaut Capabilities Update March 2026: Fill/Finish
3/10/2026
Aseptic, isolator‑based fill‑finish spans multiple formats and batch sizes, supported by onsite analytics that cut hand‑offs and streamline testing. Learn how this setup boosts efficiency.
-
Fujifilm Biotechnologies Capabilities Update March 2026: Large Molecule
3/10/2026
An overview of manufacturing strategies and scaling options shows how aligned systems, smart planning, and flexible models support biologics from early development to commercialization.
-
ProBio Capabilities Update March 2026: Large Molecule
3/10/2026
A new Center of Excellence expands capacity for genetic‑medicine programs with upgraded facilities, streamlined workflows, and early‑stage services that support readiness for PD and IND milestones.